• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Kyverna Therapeutics, Inc. - Common Stock (NQ:KYTX)

    2.110 -0.020 (-0.94%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 138,630
    Open 2.130
    Bid (Size) 2.020 (5)
    Ask (Size) 2.150 (9)
    Prev. Close 2.130
    Today's Range 2.050 - 2.200
    52wk Range 1.780 - 17.55
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Notice to Long-Term Shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Methode Electronics, Inc. (NYSE: MEI); ModivCare, Inc. (NASDAQ: MODV); and Monolithic Power Systems, Inc. (NASDAQ: MPWR) - Grabar Law Office Is Investigating Claims on Your
    From Grabar Law Office
    Via GlobeNewswire
    ALERT: Grabar Law Office Investigates Claims for Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); and Virtu Financial, Inc. (NASDAQ: VIRT)
    From Grabar Law Office
    Via GlobeNewswire

    Performance

    YTD
    -46.2%
    -46.2%
    1 Month
    +8.8%
    +8.8%
    3 Month
    -29.7%
    -29.7%
    6 Month
    -60.1%
    -60.1%
    1 Year
    -85.5%
    -85.5%

    More News

    Read More
    Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeutics, Inc. (Nasdaq: KYTX): Grabar Law Office is
    From Grabar Law Office
    Via GlobeNewswire
    Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your
    From Grabar Law Office
    Via GlobeNewswire
    Notice to Long-Term Shareholders of Archer-Daniels-Midland Co. (NYSE: ADM); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Kyverna Therapeutics, Inc. (Nasdaq: KYTX); and Mercury Systems, Inc. (Nasdaq: MRCY): Grabar Law Office is Investigating Claims on Your
    From Grabar Law Office
    Via GlobeNewswire
    Top movers in Monday's after hours session
    Via Chartmill
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Notice to Long-Term Shareholders of Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Is Investigating Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    Deadline Soon: Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    KYTX Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    KYTX Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kyverna, Sun Communities, DMC Global, and Marqeta and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    KYVERNA THERAPEUTICS 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - KYTX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    KYTX Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit
    Via NewMediaWire
    Topics Initial Public Offering Lawsuit
    Exposures Financial Legal Securities Market
    KYTX Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit
    Via TheNewswire.com
    Topics Initial Public Offering Lawsuit
    Exposures Financial Legal Securities Market
    KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Kyverna Therapeutics, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    KYTX Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit
    Via NewMediaWire
    Topics Initial Public Offering Lawsuit
    Exposures Financial Legal Securities Market
    KYTX Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit
    Via TheNewswire.com
    Topics Initial Public Offering Lawsuit
    Exposures Financial Legal Securities Market
    INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    KYTX Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    KYTX Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Filing Deadline in Class Action Lawsuit
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    Important February 7, 2025 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. Investors of Securities Fraud Class Action Lawsuit
    Via NewMediaWire
    Topics Fraud Lawsuit
    Exposures Financial Legal
    Important February 7, 2025 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. Investors of Securities Fraud Class Action Lawsuit
    Via TheNewswire.com
    Topics Fraud Lawsuit
    Exposures Financial Legal

    Frequently Asked Questions

    Is Kyverna Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Kyverna Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Kyverna Therapeutics, Inc. - Common Stock trade on?
    Kyverna Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Kyverna Therapeutics, Inc. - Common Stock?
    The ticker symbol for Kyverna Therapeutics, Inc. - Common Stock is KYTX on the Nasdaq Stock Market
    What is the current price of Kyverna Therapeutics, Inc. - Common Stock?
    The current price of Kyverna Therapeutics, Inc. - Common Stock is 2.110
    When was Kyverna Therapeutics, Inc. - Common Stock last traded?
    The last trade of Kyverna Therapeutics, Inc. - Common Stock was at 05/09/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.